Skip to main content
SpringerLink
Log in

Transcriptional modulation of the human complement factor I gene in Hep G2 cells by protein kinase C activation

  • Published:
Molecular and Cellular Biochemistry Aims and scope Submit manuscript

Abstract

This study examined the role of the protein kinase C (PKC) signalling pathway in the regulation of expression of human complement factor I (CFI) gene. The production of CFI by Hep G2 cells was enhanced in a dose- and time-dependent fashion by 12-O-tetradecanoyl-1,2-phorbol 13-acetate (TPA), a potent PKC activator. 4α-phorbol didecanoate, an inactive phorbol ester, had no effect on CFI synthesis. The TPA-dependent increase in CFI secretion was correlated with an increase in CFI mRNA levels. Forskolin, a cAMP-inducing agent, augmented the TPA response. W7, an inhibitor of protein kinase A and genistein, an inhibitor of protein tyrosine kinase(s) both did not prevent the increase in CFI expression mediated by TPA. However, calphostin C, a specific inhibitor of PKC, abolished the TPA-induced increase in CFI mRNA levels. Down regulation of intracellular PKC levels by prior exposure of Hep G2 cells to a high concentration of TPA also blocked the increase in CFI mRNA levels induced by TPA suggesting that the TPA effects were mediated via activation of PKC. mRNA decay studies indicated that the half-life of CFI mRNA in TPA-induced cells was not significantly different from control. Nuclear run-on transcriptional assays on the other hand demonstrated that whereas the CFI gene is transcribed under basal conditions in Hep G2 cells, TPA induced a 3-4 fold increase in the transcription rate of CFI gene in 24 h. The transcription rate of GAPDH gene did not change, indicating that the effects were not general on gene transcription. Transient transfections of Hep G2 cells with chloramphenicol acetyltransferase reporter gene (CAT) constructs containing a series of sequential 5′ deletions of the CFI promoter and CAT assays showed that the sequence between -136 and -130, containing an AP-1 consensus sequence (TGAGTCA) was required for the TPA response. This observation was substantiated by the finding that mutation of this AP-1 site to TttaTCA or TtAtcCA abolished the TPA responsiveness. The enhancement of the activity of transfected chimeric CAT constructs by TPA was abrogated by calphostin C and by pyrrolidine dithiocarbamate (an inhibitor of NF-κB and AP-1 transactivation). These results indicate that TPA regulation of CFI gene requires PKC signalling and is mediated by via a TPA response element (TRE) in the CFI promoter region located at -136/-130 and involves the transactivation of AP-1 and NF-κB transcription factors. We suggest that PKC may be one of the intracellular pathways that control CFI gene expression and that cellular processes (involving growth factors, hormones, cytokines etc.) that activate PKC may upregulate the expression of the CFI gene.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Fearon DT: Purification of C3b inactivator and demonstration of its two polypeptide chain structures. J Immunol 119: 1248–1259, 1977

    Google Scholar 

  2. Pangburn MK, Schreiber RD, Muller-Eberhard HJ: Human C3b inactivator: Isolation, characterisation and demonstration of an absolute requirement for serum protein β1H for cleavage of C3b and C4b in solution. J Exp Med 146: 257–270, 1977

    Google Scholar 

  3. Ross GD, Lambris JD, Cain JA, Newman SL: Generation of three different fragments of bound C3 with purified factor I or serum.1. Requirements for factor H vs. CR1 co-factor activity. J Immunol 129: 2051–2060, 1982

    Google Scholar 

  4. Seya T, Turner JR, Atkinson JP: Purification and characterisation of a membrane protein (gp 45–70) that is a co-factor for cleavage of C3b and C4b. J Exp Med 163: 837–855, 1986

    Google Scholar 

  5. Nagasawa S, Ichihara C, Stroud RM: Cleavage of C4b by C3b inactivator: Production of a nicked form of C4b, C4b′, as an intermediate cleavage product of C4b by C3b inactivator. J Immunol 125: 578–582, 1980

    Google Scholar 

  6. Ahearn JM, Fearon DT: Structure and function of the complement receptors, CR1 (CD35) and CR2 (CD21). Adv Immunol 46: 183–219, 1989

    Google Scholar 

  7. Thornton BP, Vetvicka V, Ross GD: Function of C3 in a humoral response: iC3b/C3dg bound to an immune complex generated with natural antibody and a primary antigen promotes antigen uptake and the expression of co-stimulatory molecules by all B cells, but only stimulates immunoglobulin synthesis by antigen-specific B cells. Clin Exp Immunol 104: 531–537, 1966

    Google Scholar 

  8. Fischer MB, Ma M, Goerg S, Zhou X, Xia J, Finco O, Han S, Kelsoe G, Howard RG, Rothstein TL, Kremmer E, Rosen FS, Carroll MC: Regulation of the B cell response to T-dependent antigens by classical pathway complement. J Immunol 157: 549–556, 1996

    Google Scholar 

  9. Rasmussen JM: Inherited deficiencies of complement proteins with special reference to congenital deficiency of the regulatory protein factor I. APMIS 20(suppl): 5–89, 1991

    Google Scholar 

  10. Vyse TJ, Morley BJ, Bartok I, Theodoridis EL, Davies KA, Webster DB, Walport MJ: The molecular basis of hereditary complement factor I deficiency. J Clin Invest 97: 925–933, 1996

    Google Scholar 

  11. Goldberger G, Arnaout MA, Aden D, Kay R, Rits M, Colten HR: Biosynthesis and postsynthetic processing of human C3b/C4b inactivator (Factor I) in three hepatoma cell lines. J Biol Chem 259: 6492–6497, 1984

    Google Scholar 

  12. Julen N, Dauchel H, Lemercier C, Sim RB, Fontaine M, Ripoche J: In vitro biosynthesis of complement factor I by human endothelial cells. Eur J Immunol 22: 213–217, 1992

    Google Scholar 

  13. Guc D, Gulati P, Lemercier C, Lappin D, Birnie GD, Whaley K: Expression of the components and regulatory proteins of the alternative complement pathway and the membrane attack complex in normal and diseased synovium. Rheumatol Int 13: 136–146, 1993

    Google Scholar 

  14. Goldberger G, Bruns GAP, Rits M, Edge MD, Kwiatkowski DJ: Human complement factor I: Analysis of cDNA-derived primary structure and assignment of its gene to chromosome 4. J Biol Chem 262: 10065–10071, 1987

    Google Scholar 

  15. Shiang R, Murray JC, Morton CC, Buetow KH, Wasmuth JJ, Olney AH, Sanger WG, Goldgerber G: Mapping of the human complement factor I gene to 4q25. Genomics 4: 82–86, 1989

    Google Scholar 

  16. Vyse TJ, Bates GP, Walport MJ, Morley BJ: The organization of the human complement factor I gene (IF): A member of the serine protease family. Genomics 24: 90–98, 1994

    Google Scholar 

  17. Minta J O, Fung M, Turner S, Eren R, Zemach L, Rits M, Goldberger G: Cloning and characterization of the promoter for the human complement factor I (C3b/C4b inactivator) gene. Gene 208: 17–24, 1988

    Google Scholar 

  18. Smale ST, Schmidt M, Berk A, Baltimore D: Transcriptional activation by Sp1 as directed through TATA or initiator: Specific requirement for mammalian transcription factor IID. Proc Natl Acad Sci USA 87: 4509–4513, 1990

    Google Scholar 

  19. Minta JO, Fung M, Paramaswara B: Transcriptional and posttranscriptional regulation of complement factor I (CFI) gene expression in Hep G2 cells by interleukin-6. Biochim Biophys Acta 1442: 286–295, 1998

    Google Scholar 

  20. Karin M: Signal transduction and gene control. Curr Opin Cell Biol 3: 467–473, 1991

    Google Scholar 

  21. Chirgwin JM, Przybyla AE, MacDonald RJ, Rutter WJ: Isolation of biologically active ribonucleic acid from sources enriched in ribonucleases. Biochemistry 18: 5294–5299, 1979

    Google Scholar 

  22. Ogita K, Koide H, Kikkawa U, Kishimoto A, Nishizuka Y: The heterogeniety of protein kinase C in signal transduction cascade. Adv Sec Mess Phosphoprot Res 24: 218–223, 1990

    Google Scholar 

  23. Kobayashi E, Nakano H, Morimoto M, Tamaoki T: Calphostin C (UCN-1028C), a novel microbial compound, is a highly potent and specific inhibitor of protein kinase C. Biochem Biophys Res Commun 159: 548–553, 1989

    Google Scholar 

  24. Hidaka H, Sasaki Y, Tanaka T, Endo T, Ohno S, Fujii Y, Nagata T: N-(6-aminohexyl)-5-chloro-1-naphthalenesulfonamide, a calmodulin antagonist, inhibits cell proliferation. Proc Natl Acad Sci USA 78: 4354–4357, 1981

    Google Scholar 

  25. Akiyama T, Ishida J, Nakagawa S, Ogawara H, Watanabe S, Itoh H, Shibuya M, Fukami Y: Genistein, a specific inhibitor of tyrosine-specific protein kinases. J Biol Chem 262: 5592–5595, 1987

    Google Scholar 

  26. Sambrook J, Fritsch EF, Maniatis T: Molecular Cloning: A Laboratory Manual. 2nd edition. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY, 1989

    Google Scholar 

  27. Wong MJ, Goldgerger G, Isenman DE, Minta JO: Processing of human factor I in cos-1 cells co-transfected with factor I and paired basic amino acid cleaving enzyme (PACE) cDNA. Mol Immunol 32: 379–386, 1995

    Google Scholar 

  28. Minta JO, Wong MJ, Kozak CA, Kunnath-Muglia LM, Goldberger G: cDNA cloning, sequencing and chromosomal assignment of the gene for mouse complement factor I (C3b/C4b): Identification of a divergent segment in factor I. Mol Immunol 33: 101–112, 1966

    Google Scholar 

  29. Vandenbrouck Y, Janvier B, Loriette C, Bereziat G, Mangeney-Andreani M: Thyroid hormone modulates apolipoprotein-A1 gene expression at the post-transcriptional level in Hep G2 cells. Eur J Biochem 231: 126–132, 1995

    Google Scholar 

  30. Chomczynski P, Sacchi N: Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 162: 156–159, 1987

    Google Scholar 

  31. Nishizuka Y: Studies and perspectives of protein kinase C. Science 233: 305–312, 1986

    Google Scholar 

  32. Knudsen H, Olesen T, Riccio A, Ungaro P, Christensen L, Andreasen PA: A common response element mediates differential effects of phorbol esters and forskolin on type-1 plasminogen activator inhibitor gene expression in human breast carcinoma cells. Eur J Biochem 220: 63–74, 1994

    Google Scholar 

  33. Schreck R, Meier B, Maennel DN, Droge W, Baeuerle PA: Dithiocarbamates as potent inhibitors of nuclear factor κ-B activation in intact cells. J Exp Med 175: 1181–1194, 1992

    Google Scholar 

  34. Nishizuka Y: The role of protein kinase C in cell surface signal transduction and tumor promotion. Nature 308: 693–698, 1984

    Google Scholar 

  35. Kikkawa U, Nishizuka Y: The role of protein kinase C in transmembrane signaling. Ann Rev Cell Biol 2: 149–178, 1986

    Google Scholar 

  36. Shearman MS, Sekiguchi K, Nishizuka Y: Modulation of ion channel activity: A key function of the protein kinase C enzyme family. Pharmacol Rev 41: 211–237, 1989

    Google Scholar 

  37. Dekker LV, Parker PJ: Protein kinase C – a question of specificity. Trends Biochem Sci 19: 73–77, 1994

    Google Scholar 

  38. Kikkawa U, Kishimoto A, Nishizuka Y: The protein kinase C family: Heterogeneity and its implications. Ann Rev Biochem 58: 31–44, 1989

    Google Scholar 

  39. Newton AC: Protein kinase C: Structure, function and regulation. J Biol Chem 270: 28495–28498, 1995

    Google Scholar 

  40. Angel P, Karin M: The role of Jun, Fos and the AP-1 complex in cell proliferation and transformation. Biochim Biophys Acta 1072: 129–157, 1991

    Google Scholar 

  41. Lee W, Mitchell P, Tjian R: Purified transcription factor AP-1 interacts with TPA-inducible enhancer elements. Cell 49: 741–752, 1987

    Google Scholar 

  42. Vogt RK, Bos TJ: The oncogene jun and nuclear signalling. Trends Biochem Sci 14: 172–175, 1989

    Google Scholar 

  43. Treisman R: Transient accumulation of c-fos RNA following serum stimulation requires a conserved 5′ element and c-fos 3′ sequences. Cell 42: 889–902, 1985

    Google Scholar 

  44. Imagawa M, Chiu R, Karin M: Transcription factor AP-2 mediates induction by two different signal transduction pathways: Protein kinase C and cAMP. Cell 5: 251–260, 1987

    Google Scholar 

  45. D'Angelo DD, Oliver BG, Davis MG, McClusky TS, Dom GW: Novel role for Sp1 in phorbol ester enhancement of human platelet thromboxane receptor gene expression. J Biol Chem 271: 19696–19704, 1996

    Google Scholar 

  46. Leonardo MJ, Baltimore D: NF-κB: A pleiotropic mediator of inducible and tissue specific gene control. Cell 58: 227–229, 1989

    Google Scholar 

  47. Baldwin AS, Jr: The NF-kappa B and I kappa B proteins: New discoveries and insights. Ann Rev Immunol 14: 649–683, 1996

    Google Scholar 

  48. Stein B, Baldwin AS Jr, Ballard DW, Greene WC, Angel P, Herrlich P: Cross-coupling of the NF-κB p65 and Fos/Jun transcription factors produces potentiated biological function. EMBO J 12: 3879–3891, 1993

    Google Scholar 

  49. Stein B, Cogswell PC, Baldwin AS Jr: Functional and physical association between NF-kappa B and C/EBP family members: A Rel domain-bZIP interaction. Mol Cell Biol 13: 3964–3974, 1993

    Google Scholar 

  50. Boyle W J, Smeal T, Defize LHK, Angel P, Woodgett JR, Karin M, Hunter T: Activation of protein kinase C decreases phosphorylation of c-Jun at sites that negatively regulate its DNA-binding activity. Cell 64: 573–584, 1991

    Google Scholar 

  51. Angel P, Imagawa M, Chiu R, Stein B, Imbra RJ, Rahmsdorf HJ, Jonat C, Herrlich P, Karin M: Phorbol ester-inducible genes contain a common cis element recognized by a TPA-modulated transacting factor. Cell 49: 729-729, 1987

    Google Scholar 

  52. Schreck R, Meier B, Maennel DN, Droge W, Baeuerle PA: Dithiocarbamates as potent inhibitors of nuclear factor κ-B activation in intact cells. J Exp Med 175: 1181–1194, 1992

    Google Scholar 

  53. Meyer M, Schreck R, Baeuerle PA: Hydrogen peroxide and antioxidants have opposite effects on activation of NF-κB and AP-1 in intact cells: AP-1 as secondary antioxidant-responsive factor. EMBO J 12: 2005–2015, 1993

    Google Scholar 

  54. Li J-J, Westergaard C, Ghosh P, Colburn NH: Inhibitors of both nuclear factor-κB and activator protein-1 activation block the neoplastic transformation response. Cancer Res 57: 3569–3576, 1997

    Google Scholar 

  55. Otte AP, van Run P, Heideveld M, van Driel R, Durston A: Neural induction is mediated by cross-talk between the protein kinase C and cyclic AMP pathways. Cell 58: 641–648, 1989

    Google Scholar 

  56. Yoshimasa T, Sibley DR, Bouvier M, Lefkowitz RJ, Caron MG: Crosstalk between cellular signaling pathways suggested by phorbol-esterinduced adenylate cyclase phosphorylation. Nature 327: 67–70, 1978

    Google Scholar 

  57. Santell L, Levin EG: Cyclic AMP potentiates phorbol ester stimulation of plasminogen activator release and inhibits the secretion of plasminogen activator inhibitor-1 from human endothelial cells. J Biol Chem 263: 16802–16808, 1988

    Google Scholar 

  58. Serkkola E, Hurme M: Synergism between protein kinase C and cAMP-dependent pathways in the expression of the interleukin-1b gene is mediated via the activator-protein-1 (AP-1) enhancer activity. Eur J Biochem 213: 243–249, 1993

    Google Scholar 

  59. Mehmet H, Morris C, Rozengurt E: Multiple synergistic signal transduction pathways regulate c-fos expression in Swiss 3T3 cells: The role of cyclic AMP. Cell Growth Diff 1: 293–298, 1990

    Google Scholar 

  60. Auwerx J, Sassone-Corsi P: IP-1: A dominant inhibitor of Fos/ Jun whose activity is modulated by phosphorylation. Cell 64: 983–993, 1991

    Google Scholar 

  61. Locker J: Transcription controls: Cis elements and trans-factors. In: B.D. Hames, S.J. Higgins (eds). Gene Transcription: A Practical Approach. IRL Press, Oxford University Press, Oxford, 1993

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Laboratory Medicine and Pathobiology, Faculty of Medicine, University of Toronto, Toronto, Canada, M5S 1A8

    Joe Minta & May Fung

Authors
  1. Joe Minta
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. May Fung
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Minta, J., Fung, M. Transcriptional modulation of the human complement factor I gene in Hep G2 cells by protein kinase C activation. Mol Cell Biochem 201, 111–123 (1999). https://doi.org/10.1023/A:1007064602321

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1023/A:1007064602321

Search

Navigation